Current methods for genome engineering in mycobacteria rely on relatively inefficient recombination systems that require the laborious construction of a long double-stranded DNA substrate for each desired modification. We combined two efficient recombination systems to produce a versatile method for high-throughput chromosomal engineering that obviates the need for the preparation of double-stranded DNA recombination substrates. A synthetic "targeting oligonucleotide" is incorporated into the chromosome via homologous recombination mediated by the phage Che9c RecT annelase. This oligo contains a site-specific recombination site for the directional Bxb1 integrase (Int), which allows the simultaneous integration of a "payload plasmid" that contains a cognate recombination site and selectable marker. The targeting oligo and payload plasmid are co-transformed into a RecT-and Intexpressing strain, and drug-resistant homologous recombinants are selected in a single step. A library of reusable target-independent payload plasmids is available to generate knockouts and promoter replacements, or to fuse the C-terminal-encoding regions of target genes with tags of various functionalities. This new system is called ORBIT (Oligo-mediated Recombineering followed by Bxb1
INTRODUCTION
Following the use of laborious plasmid co-integration schemes that dominated the early days of gene replacement in bacteria, recent advances in genetic engineering of bacterial strains have largely relied on phage recombination systems, both site-specific and homologous. For example, it was recognized in 1994 that the use of non-replicating plasmids containing phage lambda attP sites could be incorporated into the E. coli chromosome via integration into the bacterial attB site. Such an event was dependent on the expression of a phage Integrase 1 . Thus, genes expressed from endogenous or regulatable promoters could be delivered into the stable confines of the chromosome in single copy, without the worry of the physiological artifacts of excessive gene copy number or the instability of selfautonomous replication vectors. Site-specific recombination (SSR) systems were the basis for developing the Lambda InCh method for transferring exogenous genes to the E. coli attB site 2 , the series of CRIM plasmids that take advantage of a variety of different phage attB sites in E. coli 3 , and many technical modifications of these SSR systems and their substrates for use in a variety of metabolic and genetic engineering protocols in a variety of organisms [4] [5] [6] [7] [8] .
In addition to these site-specific recombination systems, general homologous recombination (HR) systems of phage, such as the Red system of phage lambda, and the RecET systems of Rac prophage and MTb phage Che9c, have been widely used for genetic engineering in a variety of bacteria [9] [10] [11] [12] [13] [14] [15] ; for reviews, see [16] [17] [18] . Termed "recombineering", these procedures have used both dsDNA PCR substrates and ssDNA oligos for generating bacterial chromosomal modifications in E. coli, and in various bacterial pathogens including enterohemorrhagic E. coli., Salmonella enterica, Shigella flexneri, Pseudomonas aeruginosa, Yersinia pestis, and M. tuberculosis 14, 15, [19] [20] [21] [22] [23] [24] [25] [26] . These general phage recombination systems have also been used for the development of new methodologies for metabolic engineering of industrial microorganisms 27-36 . The Red system annealase λ Beta protein, in particular, has been employed in many protocols for the systematic modification of E. coli, for instance, by electroporation of oligos targeting the promoter regions of genomic targets allowing for accelerated evolution of E. coli for specific metabolic engineering purposes 37 . In concert with these homologous recombination systems, SSR systems described above have been employed to remove selectable drug cassettes for the construction of marker-less gene deletions and fusions 10, 12, 38 .
The new system described in this report couples the recombinogenic annealing of an oligo and the site-specific insertion of a non-replicating plasmid into a one-step procedure for generating chromosomally tagged genes, deletions, or promoter replacements in M. smegmatis or M. tuberculosis (MTb) . It is the first general chromosomal engineering technique that produces a drug-selectable recombinant that does not require the use of either target-specific dsDNA plasmids or PCR-generated recombination substrates. The only target-specific substrate requirement for gene modification is a chemically synthesized oligo. This "targeting oligo" carries the ssDNA version of the Bxb1 phage attP site (48 bases) flanked by 45-70 bases of homology to the chromosomal target, and is co-electroporated with a non-replicating "payload plasmid" that contains a Bxb1 attB site. The host (M. smegmatis or M. tuberculosis) contains a plasmid that expresses both the Che9c phage RecT annealase and the Bxb1 phage Integrase. RecT promotes annealing of the targeting oligo to the lagging strand template of the replication fork, thus placing the attP site into a precise location in the chromosome dictated by the oligo sequence. In the same outgrowth period, Bxb1 integrase promotes site-specific recombination between the co-electroporated attB-containing payload plasmid and the oligo-derived attP site. In this system, the sequence of the oligo defines the position of the insertion site and the plasmid delivers the payload.
For knockouts, the oligo is designed so that attP replaces the target gene. For C-terminal tags, the oligo is designed to insert attP at the end of the coding sequence. In this case, the type of C-terminal tag desired is defined by the selection of the plasmid to be co-electroporated with the oligo from a library of pre-existing payload plasmids. Inherent in this system, an oligo designed to create a C-terminal tag can be used with multiple plasmids to create fluorescent, degradation, and epitope tagged fusions. This new gene modification scheme is called ORBIT (for Oligo Recombineering followed by Bxb1-Integrase Targeting). We describe the use of the system to generate over 100 gene knockouts and fusions in M. smegmatis and M. tuberculosis at high efficiency.
RESULTS

RecT-promoted Oligo-mediated Recombineering -60 bp insertion
Two different types of recombineering methodologies have been applied to mycobacteria, but neither represents a broadly generalizable approach for genome engineering. Target-specific dsDNA substrates can be used to make diverse and selectable mutations. However, even the smallest useful recombination substrates consist of both a selectable marker and ~500 bp of flanking homology to the chromosome. These dsDNA constructs are cumbersome to generate for each desired mutation, and even these large substrates recombine at relatively low-efficiency. In contrast, single-stranded oligos are easily synthesized and can be used to alter one or a few bases of the chromosome at high efficiency.
However, these mutations are generally not selectable and therefore difficult to isolate. An ideal method would leverage easily synthesized and highly efficient oligonucleotide substrates to make selectable mutations. We sought to accomplish this by encoding a phage attachment site (attP) in the oligo that could be used to integrate a selectable marker at a specific chromosomal site via site-specific recombination.
To test this idea, an assay was designed to measure the frequency of incorporation of an oligo containing an insertion of approximately the size of a 48 bp attP site into the mycobacterial chromosome. For this purpose, a hygromycin resistance gene, with an internal 60 bp deletion, was integrated into the L5 phage attachment site of the M. smegmatis chromosome. Oligos (180-mers) targeting the lagging strand template of the impaired Hyg R marker and containing the missing 60 bases (as well as 60 bases flanking the deletion site) were electroporated into M. smegmatis expressing the Che9c RecT annealase from the anhydrotetracycline (ATc)-inducible Ptet promoter (pKM402) 39 . The frequency of oligo incorporation was determined as the number of Hyg R transformants among the survivors of electroporation. The number of Hyg R transformants generated varied from less than 10 to over 300, depending on the amount of oligo used ( Fig. 1b ). At about 1 μg of oligo, the total number of Hyg R recombinants plateaued at approximately 350 transformants per electroporation, which corresponds to a frequency of 2 x 10 -6 recombinants per survivor of electroporation. In an experiment where the target contained a 1 bp change creating a premature stop codon in the hyg-resistance gene, a 60 base oligo was used to restore Hyg resistance at a frequency of 4 x 10 -4 recombinants per survivor of electroporation. Thus, the RecT annealase is capable of integrating an oligo that contains a 60 base insertion into the mycobacterial chromosome, albeit at a frequency which is ~500-fold lower relative to a single base pair change.
Development of ORBIT
To convert the recombineering of an oligo into a selectable event, we determined if coelectroporation of the attP-containing oligo with an attB-containing non-replicating vector (Hyg R ) into a cell that expresses both the RecT annealase and the phage Bxb1 Integrase would allow for both homologous and site-specific recombination events to occur within the same outgrowth period. Since the oligo is designed to direct the integration of the genetic information contained in the non-replicating plasmid, these elements were termed, "targeting oligo" and "payload plasmid".
Two plasmids were generated to test this methodology ( Fig. 2 ). pKM444 produces the recombination functions. This mycobacterial shuttle vector expresses both the Che9c phage RecT annealase and the Bxb1 phage integrase (Int) from the Ptet promoter ( Fig. 2a ). pKM446 is a payload plasmid that will not replicate in mycobacteria. This vector encodes a hyg resistance marker for selection in mycobacteria and a Bxb1 attB site ( Fig. 2b ). Adjacent to the attB site is a sequence encoding both a Flag tag and a DAS+4 peptide tag designed to be in frame with a targeted chromosomal gene following integration of the plasmid. The DAS+4 tag directs a fusion protein for degradation via the ClpXP system upon expression of the SspB adapter protein 40, 41 . Targeting oligos were designed to direct the integration of attP to the 3' ends of the M. smegmatis recA, DivIVA and leuB genes, just in front of the stop codon. A site-specific recombination event between the inserted attP and the coelectroporated pKM446 would then generate a DAS+4 fusion to these target genes (see Supplementary   Table 1 for the list of oligos used in this study). Targeting oligos, which anneal to the lagging strand template of the replication fork, were co-electroporated with the pKM446 payload plasmid into M. smegmatis that expressed both Che9c RecT annealase and Bxb1 Integrase. Among the Hyg R colonies resulting from these transformations, 9 out of 12 candidates tested by PCR contained the expected recombination structure, in which pKM446 was inserted between attR and attL sites at the predicted oligo-directed integration site ( Fig. 2 c-e). The fusion of the target genes to the Flag-DAS+4 degradation tag was verified by sequencing the PCR products of the 5' junctions. The sequence of the recA-Flag-DAS+4 fusion generated by ORBIT is shown in Supplementary Fig. 1 .
To test the functionality of the tag and verify that the mutated locus was the only copy of the targeted gene in the cell, we took advantage of the protein degradation system for controlling the expression of DAS+4-tagged proteins in M. smegmatis and M. tuberculosis [42] [43] [44] . In this system, the degradation of the DAS+4 tagged protein is promoted by expression of the E. coli SspB protein. Two different sspB expression systems were used, which induce degradation of the target protein either by adding ATc (Tet-OFF) or removing ATc (Tet-ON).
Cells containing the recA-DAS+4 fusion were transformed with pGMCgS-TetON-18, allowing the induction of SspB in the absence of ATc; RecA function was quantified using a UV resistance assay.
When grown in the presence of ATc, the recA-DAS+4-tagged strain containing either the SspBexpressing plasmid or control plasmid showed similar levels of UV sensitivity ( Fig. 3a right) . In contrast, the sensitivity of the tagged strain with SspB was enhanced in the absence of ATc (Fig. 3a left) .
The divIVA and leuB DAS+4-tagged strains were transformed with pGMCgS-TetOFF-18, which produces SspB upon ATc addition. In both cases, addition of ATc inhibited the growth of these mutants, consistent with the essentiality of these genes on the media used in this study ( Fig. 3b & c) .
The defect of LeuB depletion could be reversed by the addition of leucine to the plates, verifying that that this phenotype was linked to the engineered mutation (not shown). Thus, the ORBIT method could generate function-altering mutations without the need to construct either target-specific plasmids or long dsDNA recombineering substrates.
The scheme of using both RecT and Bxb1 Integrase simultaneously to promote modification of a chromosomal target gene is diagramed in Fig. 4 ; the process is called ORBIT (for Oligo-mediated Recombineering followed by Bxb1 Integrase Targeting). In theory, targeting oligos could also be designed to delete a portion of the chromosome during the ORBIT reaction ( Fig. 4 , right side) to create deletions. Demonstrations of such ORBIT-promoted knockouts are described bellow.
Parameters of ORBIT-promoted gene targeting
Two features of ORBIT that were optimized are the length of the homologous arms (HAs) in the targeting oligo, and the relative amounts of oligo and non-replicating plasmid used for coelectroporation. The HAs of a polA-targeting oligo were varied from 50 to 70 bases (oligo lengths, including attP, were from 148 to 188 bases). The oligos were mixed with 200 ng of pKM446 and transformed into M. smegmatis containing pKM444. While there is variability in the number of Hygresistant transformants from each electroporation, oligos containing longer HAs produced more transformants ( Fig. 5a ). Below 40 base pair HAs, no Hyg R transformants are observed above the number seen in the no oligo control.
We also examined the optimal ratio of oligo to plasmid. An optimal concentration of targeting oligo (1 μg) was co-electroporated with various amounts of the payload plasmid pKM446. More Hyg R transformants are observed when more plasmid is used, but there is also a small increase in the number of oligo-independent transformants that presumably represent illegitimate recombinants ( Fig. 5b ). PCR screening confirmed that 39/40 Hyg-resistant transformants recovered in this experiment (using 8 candidates of each transformation), represented the desired oligo-directed recombination events. As a rule, we generally combined 1 μg of oligo with 200 ng of plasmid in the transformations described below.
ORBIT-promoted knockdowns and knockouts in M. smegmatis and M. tuberculosis
To determine if ORBIT-promoted modifications could be generally engineered throughout the chromosome, we targeted a variety of genes in M. tuberculosis and M. smegmatis. For C-terminal tags, the attP site was placed just in front of the stop codon of the target gene. For knockouts, the attP site was flanked by 60-70 bases, which included the first and last 10 codons of the target gene (including the start and termination codons), which is expected to result in the deletion of intervening chromosomal sequence. Overall, we have made over 100 strains where the target genes have either been deleted or C-terminally tagged (see In order to cure recombinants of the RecT-Int producing plasmid following modification, a sacBcontaining derivative of pKM444 was constructed (pKM461). A number of genes were tagged in a pKM461-bearing strain (including recG, dnaN and ftsK), then plated directly on Hyg-sucrose plates to both select for the recombinant and to cure the strain of the RecT-Int producer. This process appears to produce fewer colonies than previously observed with pKM444, but can rapidly produce plasmid-free mutants.
Genetic modifications with ORBIT should be very stable. An excision event promoted by the Bxb1 SSR system requires an additional factor called gp47 45 , which is not present in the hosts used for these experiments. The stability of ORBIT-mediated modifications was verified by observing that the integrated payload plasmid, in a number of M. smegmatis mutants generated in this study, was not lost after more than 100 generations of growth in the absence of drug selection. The one exception was dnaK-Flag-DAS+4, a fusion that could be constructed, but was lost spontaneously in subsequent outgrowth periods, as evidenced by the loss of plasmid-chromosome junctions. Apparently, this important chaperone cannot sustain the presence of the tag on its C-terminal end, especially during a stress period such as selection on sucrose for the curing of sacB-containing plasmids.
Expanding the library of ORBIT-mediated modifications
In order to expand the types of modifications that can be made via ORBIT, we built a set of payload plasmids all containing the Bxb1 attB site fused to different types of tags. In addition to the Flag-DAS+4 plasmids, we generated plasmids to create C-terminal targeted fusions with combinations of eGFP, mVenus, SNAP, CLIP, Myc and His epitopes, and TEV cleavage sites. These tags facilitate both protein localization by fluorescence and tandem affinity purification ( Table 3 ). In addition, we created plasmids to generate chromosomal knockouts and promoter replacements using either hygromycin or zeocin resistance as a selection for the recombinant (see Table 3 ). Any number of payload plasmids can be matched with a single targeting oligo to generate a variety of functional gene modifications.
As with any chromosomal engineering method, one must consider the effect of the modification on expression of downstream functions, especially if the target gene is within an operon. The ORBIT knockout plasmid pKM464 was designed so that once integrated, the hyg gene is positioned at the junction of the insertion site allowing downstream genes to be transcribed by the hyg promoter. In our experience, this is generally sufficient for the generation of most mutations (see Table 1 for knockouts generated in M. smegmatis). For additional options, variants of pKM446 (for Flag-DAS+4 tags) or pKM464 (for knockouts) are designed that contain a second promoter (P GroEL ) to drive higher transcription downstream of the insertion site, if needed (Table 3) . Similar plasmids can be generated with promoters of varying strengths, as needed.
GFP fusions
To demonstrate the functionality of these additional tags, ORBIT was used to construct eGFP fusions with a number of M. smegmatis genes. We tagged MmpL3 (the essential mycolate transporter suspected to reside at the pole) and DnaN (the beta subunit of DNA polymerase III), two proteins known to be located in discrete cytoplasmic foci, and three genes with unknown distribution patterns. The eGFP payload plasmid pKM468 (Table 3 ) was used to tag each gene in situ at the endogenous chromosomal locus. MmpL3-eGFP and DnaN-eGFP were concentrated at the predicted localization site of each protein ( Fig. 7) . For DnaN-GFP, the punctate spots identify positions of the replication forks and are shown as occurring in non-polar regions of the cell (see Fig. 7 ), in accordance with previous observations 47 . eGFP-tagged alleles of MSMEG_3596, SppA and ClpC were all found at distinct sites, which were different from the diffuse cytosolic distribution of unfused eGFP. Overall, ORBIT is a quick and efficient way to tag native genes in the chromosome with different types of tags without having to create target-and modification-specific dsDNA recombination substrates. Also, by expressing each gene at its native level, aberrant localization or complex formation due to overexpression can be avoided.
Promoter replacements
One can also integrate attB-containing ORBIT plasmids to change the endogenous levels of expression of a chromosomal gene. We constructed a series of ORBIT plasmids containing promoters of different strengths that can be used to drive the expression of genes downstream of the plasmid insertion site (see Table 3 ). For use of these plasmids, the ORBIT oligo is designed to replace the endogenous promoter with attP. The target gene's ribosome binding site, if recognized, can also be deleted, replaced, or left intact, depending on the final level of expression desired. To test this scheme, we performed ORBIT in an M. smegmatis strain where a chromosomal lacZ gene is under control of the mycobacterial PAg85 promoter containing a weak ribosome-binding site.
ORBIT was used to replace PAg85 with one of three different promoters: P imyc , P GroEL or P38.
Plasmids containing these promoters were obtained from D. Schnappinger and S. Ehrt and are listed according to increasing strengths of expression (D. Schnappinger, personal communication). The promoters were transferred to ORBIT integration plasmids and placed upstream of the Bxb1 attB site (see Fig. 8a ). An optimized ribosome binding site (rbs: AGAAAGGAGGAAGGA) was included between the promoters and the attB site to increase the overall expression of β-galactosidase relative to the starting strain, where an endogenous Shine-Delgarno sequence could not be recognized. ORBIT recombinants were identified by resistance to zeocin and verified by chromosomal PCR analysis as described above. As seen in Fig. 8b , the total amount of β-galactosidase in each extract increased in accordance with the expected strengths of the three promoters used in these assays. Clearly, endogenous promoters can easily be altered using ORBIT to express different levels of a target gene.
DISCUSSION
The λ Red recombineering system has been critical for genome engineering of E. coli and related bacteria. While λ Red does not function well in bacteria more distantly related to E. coli, endogenous phage recombination systems have been identified and employed to promote recombineering in these organisms. One of the more notable examples of a phage recombination system utilized in this way is the Che9c mycobacterial ORBIT overcomes the limitations of existing methods by combining components of two different efficient recombination systems from mycobacteria: the Che9c annealase from the general homologous recombination system and the Bxb1 Integrase from the site-specific recombination system.
The construction of long dsDNA recombination substrates is replaced by the synthesis of a targeting oligonucleotide, and the availability of a library of payload plasmids allows a single oligo to be used to generate a wide variety of functional modifications. The utility of ORBIT extends beyond the simple generation of mutants. Since targeting oligos are so easily generated, the system is well suited for the construction of libraries of mutants. The targeting oligo loop containing the 48 bp attP site can be extended to 60 bp ( Fig. 1) to include a nearly infinite number of unique DNA barcode sequences, which would allow each mutant in a large ORBIT-generated pool to be monitored independently by PCR or next-generation sequencing. The variety of modifications that can be made with the existing collection of payload plasmids opens new avenues for functional screening of mutant libraries that are generated using this method. ORBIT can also be used for genome reduction strategies in MTb. The largest deletion generated in this study was the one-step 12kb deletion of the pks12 gene, and it is likely that even larger deletions are possible. Finally, though most of the payload plasmids described in this report are designed to modify endogenous genes, one could also use this system to place exogenous elements, such as large clusters of biosynthetic genes, into any specified position in the mycobacterial chromosome.
The paradigm of ORBIT is likely to be useful in many different bacterial species. The Bxb1
Integrase requires no host functions to carry out the site-specific and directional (attB x attP) recombination reaction. It is for these reasons that Bxb1 Integrase has been selectively employed for genetic manipulations in both bacterial and mammalian cells 49, 50 . Thus, the key to the development of ORBIT for other microbial systems would be to find a λ Beta or RecT-like annealase that promotes some level of oligo-mediated recombineering. Datta et al 51 have tested a number of single-stranded annealing proteins (SSAPs) from both Gram-positive and Gram-negative bacteria for oligo-mediated recombineering in E. coli. While the recombineering efficiency ranged over three orders of magnitude, some SSAPs from distant species worked as well as the λ Beta protein in E. coli, suggesting that some annealases are easily transferable between species. The annealase for use in ORBIT would have to be able to promote annealing of an oligo containing a 48 bp attP insertion. Note, however, that even if oligo recombineering occurs at low frequencies with such a substrate (~10 -6 ), the number of attP sites generated could very well be adequate for the Bxb1 Integrase to promote integration of a non-replicating plasmid, thus making integration of the oligo a selectable event.
Methods
Bacterial strains. M. smegmatis strains used in this study were derived from mc 2 155; the M. tuberculosis strains were all derived from H37Rv.
Media. M. smegmatis was grown in Middlebrook 7H9 broth with 0.05% Tween 80, 0.2% glycerol, 0.5% BSA, 0.2% dextrose, and 0.085% NaCl; transformants were selected on LB plates (DIFCO) with appropriate drugs. M. tuberculosis was grown in 7H9 broth with 0.05% Tween 80, 0.2% glycerol and OADC (Beckton-Dickinson); transformants were selected on 7H10 plates with 0.5% glycerol and OADC. When needed, antibiotics were added at the following concentrations: kanamycin (20 μg/ml), streptomycin (20 μg/ml), hygromycin (50 μg/ml), zeocin (25 μg/ml).
Plasmids. Plasmids containing the P imyc promoter 52 , the P GroEL promoter and P38 promoter were obtained from D. Schnappinger and S. Ehrt, as were plasmids pGMCgS-TetOFF-18 and pGMCgS-TetON-18, where the E. coli SspB adapter protein is under control of the wild type and reverse TetR repressors, respectively. Plasmids constructed for this study are described in Tables 3 & 4 Supplementary Fig. 2 into the target sequence file for the type of modification required (i.e., knockout, C-terminal tag, or promoter replacement) as described in the Results section. If the transcriptional direction of the target gene is pointing toward the chromosomal origin in either replicore (green arrows in Supplementary Fig. 2) , then select the top strand (5' to 3') of the "target sequence + attP" file as the lagging strand DNA in the oligo.
If the transcriptional direction of the target gene is pointing away from the chromosomal origin in either replicore (red arrows in Supplementary Fig. 2) , then select the bottom strand (5' to 3') of the "target sequence + attP" file as the lagging strand in the oligo. Example shown in Supplementary Fig. 2 glycine was added to the culture. The cells were shaken at 37 o C overnight (16-20 total hours following induction), collected by centrifugation and processed as described above, except that all steps were performed at room temperature. Recombinant colonies were picked into 5 ml 7H9-OADC-tween containing 50 μg/ml hygromycin and grown with shaking for 4-5 days at 37 o C. Fig. 3c ). In each case, the 5' junction was verified by a target-specific primer and an "oriE" primer (CCTGGTATCTTTATAGTCCTGTCG); the 3' junction was verified by a target-specific primer and a "HygC-out" primer (TGCACGGGACCAACACCTTCGTGG or GAGGAACTGGCGCAGTTCCTCTGG). In some cases, the 5' junction PCR was verified by sequencing. Target-specific primers contained sequences at least ORBIT oligo. For knockouts, an additional PCR was performed to verify the absence of the target gene in the recombinant.
PCR analysis for verification of Recombinants
Fluorescence microscopy
Bacterial cells were mounted on 1% agar pads and imaged with a DeltaVision Personal DV microscope followed by deconvolution using SoftwoRx software (Applied Precision). Further processing was performed using FIJI software 53 . Image brightness and contrast were adjusted for visibility and the files were converted to 600 dpi. Representative cells are shown from multiple images of each strain. ORBIT-generated GFP fusions. M. smegmatis cells containing GFP-tagged targets were grown in 7H9-AD-Tween-80 to an optical density of 0.8. One microliter of the culture was spotted on an agarose pad for microscopy. Each bacterial strain was imaged using differential interference contrast (DIC) and GFP channels. A TrrnB terminator is placed upstream of this promoter to prevent read-through from the plasmid backbone. The oligo is designed to place attP just upstream of the target gene in place of the endogenous promoter. Following integration, the promoter and inserted ribosome binding site drive expression of the chromosomal target gene (lacZ).
Beta-galactosidase activity assay.
(b) ORBIT was carried out with plasmids pKM496 (P GroEL ), pKM508 (P imyc ) and pKM509 (P38) with an oligo that deletes the endogenous promoter. Extracts of the cells were made and beta-galactosidase assays were performed in triplicate (standard error bars shown). The higher amounts of betagalactosidase present in the engineered strains, relative to the starting strain, is likely due to the presence of the optimized ribosome binding site following each promoter.
Supplementary Figure 1 Sequence of the recA-Flag-DAS+4 fusion. The sequence contains the C-terminal region of recA (blue), the 43 bp attR site (orange) created by a crossover between attP and attB (with the crossover core sequence in black), and a CG base pair (light blue) included in the ORBIT plasmid to fuse the 43 bp attR site with both the Flag tag (green) and the DAS+4 tag (red). Finally, the stop codon from recA is shown in blue.
Supplementary Figure 2
Design of the ORBIT oligo. To identify the lagging strand from a sequence file of a target gene (reading from the start codon 5' to 3'), first insert the attP site into the desired position. Then, use the top strand if your target gene is transcribed toward the ori sequence (e.g., green arrows), or use the bottom strand if your target gene is transcribed toward the dif region (e.g, red arrows). d  n  a  N  M  S  M  E  G  _  0  0  0  1  D  N  A  p  o  l  y  m  e  r  a  s  e  I  I  I  ,  b  e  t  a  s  u  b  u  n  i  t  n  r  m  m  p  L  3  M  S  M  E  G  _  0  2  5  0  M  m  p  L  f  a  m  i  l  y  p  r  o  t  e  i  n  n  r  s  p  p  A  M  S  M  E  G  _  1  4  7  6  s  i  g  n  a  l  p  e  p  t  i  d  e  p  e  p  t  i  d  a  s  e  n  r  c  l  p  C  M  S  M  E  G  _  6  0  9  1  A  T  P  -d  e  p  e  n  d  e  n  t  p  r  o  t  e  a  s  e  A  T  P  -b  i  n  d  i  n  g  p  r  o  t  e  i  n  n  r  -M  S  M  E  G  _  3  5  9  6 A T P a s e n r D e l e t i o n s : 
